Advancing Breast Cancer and Ovarian Cancer Research in Israel: Latest Discoveries & Innovations

Learn the latest research in advances emerging from Israel from our panel of Israeli experts. Moderated by Pnina Mor, PhD, CNM, Director of Israel Support Services, Sharsheret Israel. Guest speakers include Rachel Michaelson-Cohen, MD, Director, BRCA NOGA Clinic, Shaare Zedek Medical Center, Tal Sella, MD, Breast Oncologist, Sheba Medical Center, and Naama Srebnik-Moshe, MD, Director of the Reproductive Endocrinology Service, Shaare Zedek Medical Center. 8:00 Israel time/1:00 pm EDT/10:00 am PST.

Register by clicking here.

Interested in learning more about Sharsheret Israel or know someone in need support in Israel? Visit sharsheret.org/israel

For questions contact Pnina Mor, PhD, CNM.

Dr. Rachel Michaelson is a senior physician at Shaare Zedek Medical Center in the Department of Obstetrics and Gynecology and the Institute of Medical Genetics. Dr. Michaelson is the clinical director of the prenatal genetic unit and has recently been appointed as medical director of the BRCA carrier clinic. Her main research focus is BRCA population screening, and measures of cancer risk-reduction in BRCA carriers. She is a senior lecturer in her field at the Hebrew University School of Medicine, leads several teaching programs, and supervises multiple MD and MPH students. Dr. Michaelson has received several grants for her research projects and award for her teaching initiatives in Hebrew University.

Dr. Tal Sella is a medical oncologist specializing in the treatment of breast cancer. He graduated with honors from Tel Aviv University School of Medicine and completed his residency in medical oncology at Sheba Medical Center. He subsequently completed a clinical and research fellowship in breast cancer at Dana-Farber, a cancer center affiliated with Harvard Medical School, Boston, USA. In this framework, Dr. Sella focused on the treatment of breast cancer in young women. His research focuses on the unique characteristics of breast cancer in young women, including biological and therapeutic aspects, as well as their short- and long-term effects on the quality of life and general health of patients. He has extensive experience in work that combines patient-reported outcomes and digital solutions to support medical care. Dr. Sella has published articles in the field in leading scientific journals, his work has been presented at major oncology conferences and quoted in the media. Dr. Sella is a member of Sharsheret’s Medical Advisory Committee.

Dr. Naama Srebnik-Moshe is a specialist in obstetrics, gynecology and fertility. She is a senior physician at Shaare Zedek Medical Center in the Department of Obstetrics and Gynecology and the In Vitro Fertilization (IVF) Unit. She is Director of the Reproductive Endocrinology Service at the Shaare Zedek Medical Center. Her public positions include: Member of the Sharsheret Israel Medical Advisory Committee, member of the committee of the Israeli Society for of Pediatric and Adolescent Gynecology, and member of the gynecology specialty exam writing committee. On behalf of the Israel Menopause Society Dr. Srebnik is responsible for the general public website. She is a member of the Israel Association of Obstetrics and Gynecology, the Israeli Society for Menopause, the Israeli Society for Pediatric and Adolescent Gynecology, the Israeli Fertility Association and ESHRE- the European Society of human Reproduction and Embryology. She is a senior lecturer at the Faculty of Medicine at the Hebrew University. She is coordinator of the BRCA Medicine course at the advanced Medical Studies at the Tel Aviv University. Her research is in the field of fertility and clinical research on topics related to BRCA mutation carriers. Dr. Srebnik is the recipient of numerous awards including, Excellence in Teaching from the Hebrew University School of Medicine, Yareah scholarship for research collaboration with the Hebrew University and the Prof. Ronit Kuchman Research Doctor award in the field of fertility.